| Financial Year |
March 31 2023 |
| Monetary Funds |
473,554,372.02 |
| Held-for-trading Financial Assets |
523,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
29,070,693.91 |
| Advances to Suppliers |
30,157,162.76 |
| Other Receivables |
6,879,586.36 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,026,124,759.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,089,104.12 |
| Total Current Assets |
2,145,635,242.10 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
620,162,861.72 |
| Under-construction Projects |
153,196,275.54 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
120,710,216.24 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
20,168,244.23 |
| Deferred Income Tax Assets |
8,418,866.89 |
| Other Non-Current Assets |
4,524,686.00 |
| Sub-Total of Non-Current Assets |
927,181,150.62 |
| Total Assets |
3,072,816,392.72 |
| Short-Term Loans |
100,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
89,176,885.98 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
36,383,572.49 |
| Taxes Payable |
19,047,409.95 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
5,466,431.86 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
27,715,774.56 |
| Sub-Total of Current Liabilities |
755,740,323.26 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
16,799,386.84 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
35,653,661.84 |
| Total Liabilities |
791,393,985.10 |
| Paid-In Capital(Or Share Stock) |
309,441,175.00 |
| Capital Surplus |
451,922,737.32 |
| Surplus Reserve |
91,728,722.55 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,431,011,195.08 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,281,422,407.62 |
| Owner's Equity（Stockholder's Equity） |
2,281,422,407.62 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,072,816,392.72 |
